Airsculpt Technologies Inc (AIRS)vsHCA Healthcare, Inc. (HCA)
AIRS
Airsculpt Technologies Inc
$2.13
-10.50%
HEALTHCARE · Cap: $173.03M
HCA
HCA Healthcare, Inc.
$423.82
-0.39%
HEALTHCARE · Cap: $92.43B
Smart Verdict
WallStSmart Research — data-driven comparison
HCA Healthcare, Inc. generates 51659% more annual revenue ($78.01B vs $150.72M). HCA leads profitability with a 8.8% profit margin vs -7.8%. HCA earns a higher WallStSmart Score of 65/100 (C+).
AIRS
Hold38
out of 100
Grade: F
HCA
Buy65
out of 100
Grade: C+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+34.4%
Fair Value
$3.23
Current Price
$2.13
$1.10 discount
Margin of Safety
-76.5%
Fair Value
$301.11
Current Price
$423.82
$122.71 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Earnings expanding 200.0% YoY
Every $100 of equity generates 136 in profit
Conservative balance sheet, low leverage
Large-cap with strong market position
Attractively priced relative to earnings
Generating 1.1B in free cash flow
Areas to Watch
Smaller company, higher risk/reward
Weak financial health signals
ROE of -11.2% — below average capital efficiency
Revenue declined 2.5%
Distress zone — elevated risk
Comparative Analysis Report
WallStSmart ResearchBull Case : AIRS
The strongest argument for AIRS centers on Price/Book, EPS Growth.
Bull Case : HCA
The strongest argument for HCA centers on Return on Equity, Debt/Equity, Market Cap. PEG of 1.29 suggests the stock is reasonably priced for its growth.
Bear Case : AIRS
The primary concerns for AIRS are Market Cap, Piotroski F-Score, Return on Equity.
Bear Case : HCA
The primary concerns for HCA are Altman Z-Score.
Key Dynamics to Monitor
AIRS profiles as a turnaround stock while HCA is a value play — different risk/reward profiles.
AIRS carries more volatility with a beta of 2.29 — expect wider price swings.
HCA is growing revenue faster at 8.7% — sustainability is the question.
HCA generates stronger free cash flow (1.1B), providing more financial flexibility.
Bottom Line
HCA scores higher overall (65/100 vs 38/100). AIRS offers better value entry with a 34.4% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Airsculpt Technologies Inc
HEALTHCARE · MEDICAL CARE FACILITIES · USA
Airsculpt Technologies Inc (AIRS) is at the forefront of the aesthetic medical technology sector, specializing in its proprietary AirSculpt® procedure, which sets a new standard for minimally invasive body contouring while prioritizing patient safety and comfort. The company is aggressively expanding its network of licensed practitioners and utilizing innovative technologies to solidify its competitive advantage in the rapidly growing non-invasive cosmetic treatment market. With rising global demand for aesthetic solutions, Airsculpt is well-positioned to capture market share and broaden its service offerings, driving robust growth and long-term value for its investors.
Visit Website →HCA Healthcare, Inc.
HEALTHCARE · MEDICAL CARE FACILITIES · USA
HCA Healthcare is an American for-profit operator of health care facilities that was founded in 1968. It is based in Nashville, Tennessee, and, as of May 2020, owns and operates 186 hospitals and approximately 2,000 sites of care, including surgery centers, freestanding emergency rooms, urgent care centers and physician clinics in 21 states and the United Kingdom.
Visit Website →Compare with Other MEDICAL CARE FACILITIES Stocks
Want to dig deeper into these stocks?